NASDAQ:HSKA Heska (HSKA) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$119.99▼$119.9950-Day Range$115.55▼$119.9952-Week Range$57.83▼$120.03VolumeN/AAverage Volume241,932 shsMarket Capitalization$1.31 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Heska alerts: Email Address Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade About Heska Stock (NASDAQ:HSKA)Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado.Read More Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade HSKA Stock News HeadlinesJanuary 2, 2024 | marketwatch.comVolitionRx Shares Up 35% on $13M Milestone Payments From HeskaOctober 31, 2023 | thestreet.comWhy Heska (HSKA) Hit a One-Year High TodaySeptember 7, 2024 | Timothy Sykes (Ad)Tim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…June 8, 2023 | markets.businessinsider.comWhy eXp World Holdings Shares Are Rising ThursdayMay 19, 2023 | msn.comHeska Earnings Perspective: Return On Capital EmployedMay 11, 2023 | businesswire.comHESKA CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Heska ...May 9, 2023 | finance.yahoo.comStrong Fourth Quarter Results Supported Heska Corporation (HSKA) in Q1May 5, 2023 | finance.yahoo.comHeska (HSKA) Q1 Earnings and Revenues Lag EstimatesSeptember 7, 2024 | Timothy Sykes (Ad)Tim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…May 5, 2023 | finance.yahoo.comHeska Corporation Reports First Quarter 2023 ResultsApril 21, 2023 | finance.yahoo.comHeska Announces Annual Meeting of Stockholders on May 3, 2023April 4, 2023 | finance.yahoo.comThe three-year returns have been strong for Heska (NASDAQ:HSKA) shareholders despite underlying losses increasingApril 3, 2023 | finance.yahoo.comWhy Heska Stock Is On Fire TodayApril 3, 2023 | finance.yahoo.comMars to Acquire Heska, Global Provider of Advanced Veterinary Diagnostic and Specialty SolutionsMarch 1, 2023 | finance.yahoo.comHeska (HSKA) Q4 Earnings and Revenues Surpass EstimatesMarch 1, 2023 | finance.yahoo.comHeska Full Year 2022 Earnings: EPS Misses ExpectationsMarch 1, 2023 | finance.yahoo.comAt US$81.43, Is It Time To Put Heska Corporation (NASDAQ:HSKA) On Your Watch List?February 28, 2023 | finance.yahoo.comHeska Corporation Reports Fourth Quarter and Full Year 2022 ResultsSee More Headlines Receive HSKA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Heska and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/04/2021Today9/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolNASDAQ:HSKA CUSIPN/A CIK1038133 Webwww.heska.com Phone(970) 493-7272Fax970-619-3003Employees808Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.93) Trailing P/E RatioN/A Forward P/E Ratio266.64 P/E GrowthN/ANet Income$-19,890,000.00 Net Margins-7.86% Pretax Margin-7.91% Return on Equity0.94% Return on Assets0.67% Debt Debt-to-Equity Ratio0.23 Current Ratio5.64 Quick Ratio4.12 Sales & Book Value Annual Sales$257.31 million Price / Sales5.09 Cash Flow$1.69 per share Price / Cash Flow70.99 Book Value$39.00 per share Price / Book3.08Miscellaneous Outstanding Shares10,910,000Free Float9,572,000Market Cap$1.31 billion OptionableNot Optionable Beta1.58 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Kevin S. Wilson (Age 51)CEO, Pres & Director Comp: $988.17kMs. Catherine I. Grassman CPA (Age 47)Exec. VP & CFO Comp: $536.46kMr. Christopher D. Sveen (Age 40)EVP, Chief Admn. Officer, Gen. Counsel, Corp. Sec. & Pres of Diamond Animal Health Comp: $457.89kMr. Steven M. Eyl (Age 57)Exec. VP, Chief Commercial Officer & Pres of scil animal care company Comp: $475.28kMs. Eleanor F. Baker (Age 38)Exec. VP, MD & COO of Scil Animal Care Company Comp: $467.77kMr. Jon AagaardDirector of Investor RelationsMr. Anthony C. Providenti Jr. (Age 56)Exec. VP of Corp. Devel. Dr. Nancy Wisnewski Ph.D. (Age 60)Chief Science Advisor to CEO Daniel J. PollackVP of Imaging Operations, Treasurer & Assistant Sec.Cynthia PattersonVP of Customer CareMore ExecutivesKey CompetitorsMeridian BioscienceNASDAQ:VIVOAspira Women's HealthNASDAQ:AWHAinosNASDAQ:AIMDWBone BiologicsNASDAQ:BBLGWDIH Holding USNASDAQ:DHAIWView All Competitors HSKA Stock Analysis - Frequently Asked Questions How were Heska's earnings last quarter? Heska Co. (NASDAQ:HSKA) issued its quarterly earnings results on Thursday, November, 4th. The medical research company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.04 by $0.23. The business's revenue was up 6.4% on a year-over-year basis. What is Kevin S. Wilson's approval rating as Heska's CEO? 5 employees have rated Heska Chief Executive Officer Kevin S. Wilson on Glassdoor.com. Kevin S. Wilson has an approval rating of 57% among the company's employees. This puts Kevin S. Wilson in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Heska own? Based on aggregate information from My MarketBeat watchlists, some other companies that Heska investors own include Gilead Sciences (GILD), Exxon Mobil (XOM), Netflix (NFLX), Biogen (BIIB), AbbVie (ABBV), Amgen (AMGN) and Broadcom (AVGO). This page (NASDAQ:HSKA) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heska Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heska With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.